Each filer's latest filing for 14216R101 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (2) | ||||
| AbbVie Biotechnology Ltd 13G/A | 4.4% |
4/25/2025
Event 3/31/2025
|
||
|
HealthCap VII, L.P.
13D/A
|
0% |
9/2/2025
Event 9/2/2025
|
||
| HealthCap VII, L.P. | 0% | |||
| HealthCap VII GP LLC | 0% | |||
| Period | Filers | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 2 | 985 | $0 |
| 2026 Q2 | 1 | 785 | $4 |
| 2026 Q1 | 3 | 1.47 M | $47.9k |
| 2025 Q4 | 7 | 1.57 M | $67.0k |
| 2025 Q3 | 34 | 3.12 M | $854k |
| 2025 Q2 | 38 | 4.02 M | $1.57M |
| 2025 Q1 | 39 | 5.61 M | $1.74M |
| 2024 Q4 | 43 | 5.66 M | $2.37M |
| 2024 Q3 | 39 | 5.24 M | $5.14M |
| 2024 Q2 | 55 | 6.11 M | $7.38M |
| 2024 Q1 | 52 | 8.51 M | $19.3M |
| 2023 Q4 | 53 | 9.00 M | $22.7M |
| 2023 Q3 | 61 | 9.37 M | $32.2M |
| 2023 Q2 | 55 | 9.58 M | $84.0M |
| 2023 Q1 | 39 | 5.57 M | $10.5M |